Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v2.4.1.9
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2014
Accounting Policies [Abstract]  
Schedule of Franchisor Disclosure [Table Text Block]
   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
   
2014
   
2013
   
2014
   
2013
 
Clinics open at beginning of period
    215       130       175       82  
Clinics opened during the period
    16       24       57       74  
Clinics closed during the period
    (1 )     -       (2 )     (2 )
Clinics in operation at the end of the period
    230       154       230       154  
                                 
Clinics sold but not yet operational
                    248       254  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
   
2014
   
2013
   
2014
   
2013
 
                         
Net income (loss)
  $ (202,373 )   $ 42,547     $ (464,019 )   $ 155,899  
                                 
Weighted average common shares outstanding - basic
    4,828,122       5,340,000       4,819,861       5,340,000  
Effect of dilutive preferred shares
    -       1,335,000       -       1,335,000  
Weighted average common shares outstanding - diluted
    4,828,122       6,675,000       4,819,861       6,675,000  
                                 
Basic earnings per share
  $ (0.04 )   $ 0.01     $ (0.10 )   $ 0.03  
Diluted earnings per share
  $ (0.04 )   $ 0.01     $ (0.10 )   $ 0.02